FIG. 4.
Synthetic E7 peptides spanning residues 9 to 38 activate CDK2. (A) 16E7 (9-48) activated CDK2 in a dose-dependent manner, with peak activation at approximately 50 μM. (B) PhosphorImager quantification of data from panel A. (C) Truncation of the 16E7 (1-48) peptide sequence from the amino and carboxy termini and subsequent testing at 100 μM (A and B) demonstrate that sequences 1 to 9 and 39 to 48 are not required for CDK2 activation. Thus, 16E7 (9-38) is the minimal peptide for CDK2 activation.